People Will Become More Accepting Of Jabs: Expert
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576240_1_20210218165956.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576240-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 17:16
Dr Leung Chi-chiu speaks to Wendy Wong
A specialist in respiratory medicine said on Thursday that he believed more people would be willing to receive coronavirus vaccine once the inoculation programme is rolled out, although various surveys suggested a low acceptance rate.
Previous polls showed only between 30 and 40 per cent of Hong Kong people would get the jabs, but Dr Leung Chi-chiu said he believed their attitude would change over time.
He said he expected the public to become less worried about the vaccine’s safety as more people get inoculated.
“For something new, I think the initial acceptance may be low. That should not be a major issue because the priority groups account for about 2.4 million people. And we only have sufficient vaccine in the initial stage for one million,” he said.
“If we can roll out the programme successfully, I’m certain that the attitude will change with time. As time goes, there will be further data not only from abroad but also from the local application. That should relieve the anxiety of people who might be worried about the vaccine’s safety profile.”
He noted that an expert panel appointed by the government has yet to decide on whether the vaccine produced by mainland drug maker Sinovac can be given to elderly people aged over 60.
He said the decision would affect how quickly protection could be offered to elderly people living in care homes here.
“This is crucial because this vaccine does not require the super cold storage syringe. They can be more easily handled by the outreach teams. If they can be applied for the elderly, they can be quickly utilised to cover our old age homes,” he said.
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more
